SCHEMBL431650

SCHEMBL431650

CC(=O)c1ccc2ccccc2c1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.69
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 2/20 0.56
MAPT P10636 2/20 0.56
NSD2 O96028 1/20 0.56
POLB P06746 1/20 0.56
MCL1 Q07820 1/20 0.56
CYP1B1 Q16678 4/20 0.54
CYP1A1 P04798 3/20 0.54
ABCG2 Q9UNQ0 1/20 0.54
KDM4A O75164 1/20 0.54
CTDSP1 Q9GZU7 1/20 0.54
KDM4C Q9H3R0 1/20 0.54
CFTR P13569 1/20 0.53
LMNA P02545 1/20 0.53
HTT P42858 1/20 0.53
PLG P00747 2/20 0.53
KLK1 P06870 2/20 0.53
KLK6 Q92876 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29390177 1.00 LDHA (0.69) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL27491246 0.98 LDHA (0.67) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL27728890 0.98 LDHA (0.67) LDHAMEN1KMT2AKDM4EMAPT
Formaldehyde SCHEMBL27530553 0.96 LDHA (0.65) LDHAMEN1KMT2AKDM4EMAPT
Hydrochloric Acid SCHEMBL27640199 0.96 LDHA (0.65) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL27661040 0.93 LDHA (0.61) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL8439661 0.84 LDHA (0.64) LDHAMEN1KMT2AKDM4EMAPT
SCHEMBL27623522 0.83 LDHA (0.74) LDHAMEN1KMT2AKDM4EMAPT
Carboxynaphthol SCHEMBL25244 0.82 LDHA (1.00) LDHAMEN1KMT2AKDM4EMAPT
Carboxynaphthol SCHEMBL2099330 0.82 LDHA (1.00) LDHAMEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 US claimed
CN-115947705-B Method for preparing 1-nitrodibenzofuran by using ligand and o-bromophenol as raw materials 湖北新德晟材料科技有限公司 2024-03-19 CN claimed
CN-115286602-B Reactive fluorescent probe for generating flavonoid intermediate based on copper ion catalytic cyclization and preparation method and application thereof 新乡医学院 2023-06-16 CN claimed
CN-116178332-A N-substituted benzocoumarin compound with breast cancer resisting activity and preparation method and application thereof 新乡医学院 2023-05-30 CN claimed
CN-115947705-A Method for preparing 1-nitrodibenzofuran by using ligand and o-bromophenol as raw material 湖北新德晟材料科技有限公司 2023-04-11 CN claimed
CN-115475249-A Photoresponse carbon monoxide release nanogel and preparation method and application thereof 西北工业大学 2022-12-16 CN claimed
CN-115286602-A Reactive fluorescent probe for generating flavonoid intermediate based on copper ion catalytic cyclization and preparation method and application thereof 新乡医学院 2022-11-04 CN claimed
CN-113604127-A Water-based expansion steel structure fireproof coating and preparation method thereof 睿安天地(博野)防火材料制造有限公司 2021-11-05 CN claimed
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction BIODERM RESEARCH (US) 2008-10-16 US claimed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US claimed
US-6576372-B1 Hydroxy-containing substituent having a dipole moment is coupled to polyurethane through a NHCOO linkage NISSHINBO INDUSTRIES, INC. (JP) 2003-06-10 US claimed
US-5229243-A Addition polymer core, polyurethane or polythiourethane shell KAO CORPORATION (JP) 1993-07-20 US claimed
JP-8333296-A None JP disclosed
WO-2025041786-A1 METHOD FOR PRODUCING COMPOUND 富士フイルム和光純薬株式会社 2025-02-27 WO disclosed
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 US disclosed
US-12162863-B2 Modulators of stimulator of interferon genes (STING) Ryvu Therapeutics S.A. (PL) 2024-12-10 US disclosed
US-4189498-A FUNGICIDES, ARTHROPODICIDES BAYER AKTIENGESELLSCHAFT (DE) 1980-02-19 US disclosed
US-4132523-A PIGMENTS, DISPERSE DYES, SURFACTANT, SOLVENT, THICKENER HOECHST AKTIENGESELLSCHAFT (DE) 1979-01-02 US disclosed
US-4069385-A FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-01-17 US disclosed
US-4019857-A Process for the coloration of hydrophobic chemical fibers by metalliferous dyestuffs of cationic character PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1977-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12162863-B2 Modulators of stimulator of interferon genes (STING) STING1, IRF3, CGAS LDHA 4028/4885MEN1 2184/4885KMT2A 4721/4885
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction PSMB1, PLOD3, CUTA LDHA 2630/4885MEN1 4119/4885KMT2A 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.